Shares of a Cambridge, Massachusetts, drug firm have doubled from an eye allergy treatment trial.
Don Seiffert of the Boston Business Journal joined necn to discuss.
Read the full BBJ article here.
Shares of a Cambridge, Massachusetts, drug firm have doubled from an eye allergy treatment trial.
Don Seiffert of the Boston Business Journal joined necn to discuss.
Read the full BBJ article here.